CK-MM MYOCARDIAL INFARCTION IMMUNOASSAY

摘要

of the Invention Methods and reagents for early detection of myocardial infarction determine the level of CK-MMA and the level of the combined CK-MMA and CK-MMB in in a serum sample. From these measurements, the time of the acute phase can be more accurately determined. Novel anti-(CK-MMA) antibodies, anti-(CK-MMB) antibodies, anti-(CK-MM(A+B)) antibodies, labeled and insolubilized derivatives of these antibodies, labeled MMA, and kits containing one or more of these reagents are also described.